 |
Dapsone USP |
|---|---|
| Trade Name | Dapsone |
| Orphan Indication | For the combination treatment of Pneumocystis carinii pneumonia in conjunction with trimethoprim |
| USA Market Approval | USA |
| USA Designation Date | 1992-01-08 00:00:00 |
| Sponsor | Jacobus Pharmaceutical Company;37 Cleveland Avenue, P.O. Box 5290;Princeton, New Jersey, 08540 |
